Michael Silverman
PartnerSilverman Bain, LLPMICHAEL G. SILVERMAN, ESQ., CDME
Michael G. Silverman is an attorney and founding partner of the law firm Silverman Bain, LLP, whose practice focuses on advising healthcare professionals and entrepreneurs on all aspects of their business operations, from startups through ongoing operations and transactions.
As Certified DME Specialist who represents some of the nation’s largest providers, Michael’s unique experiences allow him to provide both expert legal and practical business insight to his clients.
A large focus of my Michael’s practice involves the nationwide representation of businesses involved in the medical equipment supply (i.e., DMEPOS) industry, such as Medicare enrolled providers, billing and marketing companies. He regularly advises such clients on regulatory compliance, payer disputes (e.g., audits and appeals), federal investigations and transactional matters.
Michael enjoys lecturing at healthcare conferences around the country to educate attendees and raise awareness of the myriad of laws applicable to their profession.
Since 2024 Michael has served on the Board of Directors for the Board of Certification/Accreditation, and in 2025 Michael was selected as one of the Top 10 Healthcare Attorneys Under 40 years old in the State of Florida.
Government Enforcement Actions: Important Case Studies
Healthcare fraud enforcement against DMEPOS suppliers continues to accelerate. Federal and state agencies are pursuing increasingly sophisticated inve
…Healthcare fraud enforcement against DMEPOS suppliers continues to accelerate. Federal and state agencies are pursuing increasingly sophisticated investigations targeting suppliers, marketers, prescribers, call centers, lead generators, technology ve
…Healthcare fraud enforcement against DMEPOS suppliers continues to accelerate. Federal and state agencies are pursuing increasingly sophisticated investigations targeting suppliers, marketers, prescribers, call centers, lead generators, technology vendors, and other participants in the DMEPOS ecosystem. Many of today's enforcement actions arise from business relationships that appear legitimate on the surface but ultimately violate federal fraud
…Healthcare fraud enforcement against DMEPOS suppliers continues to accelerate. Federal and state agencies are pursuing increasingly sophisticated investigations targeting suppliers, marketers, prescribers, call centers, lead generators, technology vendors, and other participants in the DMEPOS ecosystem. Many of today's enforcement actions arise from business relationships that appear legitimate on the surface but ultimately violate federal fraud and abuse laws.
This session examines the current civil and criminal enforcement landscape affecting the DMEPOS industry through the lens of actual enforcement actions, DOJ prosecutions, OIG investigations, and administrative actions brought against suppliers and their business partners throughout 2026. Attendees will gain a practical understanding of the arrangements that have resulted in False Claims Act liability, Anti-Kickback Statute violations, criminal prosecutions, Medicare revocations, and exclusion from federal healthcare programs.
The session will also address a growing concern within the industry: suppliers becoming involved in unlawful arrangements because evolving technologies, complex marketing models, and layered business relationships make it increasingly difficult to distinguish compliant business opportunities from illegal schemes.
Using real-world case studies and recent enforcement examples, this presentation will identify common warning signs, explain how regulators evaluate these arrangements, and provide practical guidance for conducting due diligence before entering new business relationships. Attendees will leave with a clearer understanding of today's enforcement priorities and practical steps to reduce regulatory risk while protecting their businesses.
Show MoreClick the title to see all detailsShow More